| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.56 | 0.05 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.47 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.39 | 0.2 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.3 | 0.02 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.28 | 0.03 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.3 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.22 | 0.01 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.02 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.2 | 0.006 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.2 | 0.2 |